Specific cancer-associated mutations in the switch III region of ras increase tumorigenicity by nanocluster augmentation

eLife

Volumn 4, Issue AUGUST2015, 2015, Pages 1-23

  Šolman, Maja ^a   Ligabue, Alessio ^a   Blaževitš, Olga ^a   Jaiswal, Alok ^b   Zhou, Yong ^c   Liang, Hong ^c   Lectez, Benoit ^a   Kopra, Kari ^d   Guzmán, Camilo ^a   Härmä, Harri ^d   Hancock, John F ^c   Aittokallio, Tero ^b   Abankwa, Daniel ^a  

^a ÅBO AKADEMI UNIVERSITY   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; RAS PROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANISOTROPY; ARTICLE; BIOINFORMATICS; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORECTAL CANCER; COMPUTER MODEL; CONTROLLED STUDY; DNA STRUCTURE; ENDOMETRIUM CANCER; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GENE MUTATION; NONHUMAN; PHYLOGENETIC TREE; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION; SIMULATION; SKIN CANCER; SWITCH III REGION; WESTERN BLOTTING; ANIMAL; CELL LINE; CELL MEMBRANE; CELL TRANSFORMATION; GENETICS; HUMAN; METABOLISM; MUTATION; NEOPLASM; PATHOLOGY; PROTEIN MULTIMERIZATION;

ANIMALS; CELL LINE; CELL MEMBRANE; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MUTATION; NEOPLASMS; PROTEIN MULTIMERIZATION; RAS PROTEINS; SIGNAL TRANSDUCTION;

EID: 84941364451     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.08905     Document Type: Article

References (54)

1. Abankwa D, Gorfe AA, Hancock JF. 2007. Ras nanoclusters: molecular structure and assembly. Seminars in Cell & Developmental Biology 18:599–607. doi: 10.1016/j.semcdb.2007.08.003.
2. Abankwa D, Gorfe AA, Hancock JF. 2008a. Mechanisms of Ras membrane organization and signalling: ras on a rocker. Cell Cycle 7:2667–2673. doi: 10.4161/cc.7.17.6596.
3. Abankwa D, Gorfe AA, Inder K, Hancock JF. 2010. Ras membrane orientation and nanodomain localization generate isoform diversity. Proceedings of the National Academy of Sciences of USA 107:1130–1135. doi: 10.1073/pnas.0903907107.
4. Abankwa D, Hanzal-Bayer M, Ariotti N, Plowman SJ, Gorfe AA, Parton RG, McCammon JA, Hancock JF. 2008b. A novel switch region regulates H-ras membrane orientation and signal output. The EMBO Journal 27:727–735. doi: 10.1038/emboj.2008.10.
5. Abankwa D, Vogel H. 2007. A FRET map of membrane anchors suggests distinct microdomains of heterotrimeric G proteins. Journal of Cell Science 120:2953–2962. doi: 10.1242/jcs.001404.
6. Carta C, Pantaleoni F, Bocchinfuso G, Stella L, Vasta I, Sarkozy A, Digilio C, Palleschi A, Pizzuti A, Grammatico P, Zampino G, Dallapiccola B, Gelb BD, Tartaglia M. 2006. Germline missense mutations affecting KRAS Isoform B are associated with a severe Noonan syndrome phenotype. American Journal of Human Genetics 79:129–135. doi: 10.1086/504394.
7. Cho KJ, Kasai RS, Park JH, Chigurupati S, Heidorn SJ, van der Hoeven D, Plowman SJ, Kusumi A, Marais R, Hancock JF. 2012. Raf inhibitors target Ras spatiotemporal dynamics. Current Biology 22:945–955. doi: 10.1016/j.cub.2012.03.067.
8. Cirstea IC, Gremer L, Dvorsky R, Zhang SC, Piekorz RP, Zenker M, Ahmadian MR. 2013. Diverging gain-of-function mechanisms of two novel KRAS mutations associated with Noonan and cardio-facio-cutaneous syndromes. Human Molecular Genetics 22:262–270. doi: 10.1093/hmg/dds426.
9. Cirstea IC, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D, Roberts AE, Lepri F, Merbitz-Zahradnik T, König R, Kratz CP, Pantaleoni F, Dentici ML, Joshi VA, Kucherlapati RS, Mazzanti L, Mundlos S, Patton MA, Silengo MC, Rossi C, Zampino G, Digilio C, Stuppia L, Seemanova E, Pennacchio LA, Gelb BD, Dallapiccola B, Wittinghofer A, Ahmadian MR, Tartaglia M, Zenker M. 2010. A restricted spectrum of NRAS mutations causes Noonan syndrome. Nature Genetics 42:27–29. doi: 10.1038/ng.497.
10. Cowley S, Paterson H, Kemp P, Marshall CJ. 1994. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells. Cell 77:841–852. doi: 10.1016/0092-8674(94)90133-3.
11. Cox AD, Fesik SW, Kimmelman AC, Luo J, Der CJ. 2014. Drugging the undruggable Ras: mission possible? Nature Reviews. Drug Discovery 13:828–851. doi: 10.1038/nrd4389.
12. Eccleston JF, Moore KJ, Morgan L, Skinner RH, Lowe PN. 1993. Kinetics of interaction between normal and proline 12 Ras and the GTPase-activating proteins, p120-GAP and neurofibromin. The significance of the intrinsic GTPase rate in determining the transforming ability of Ras. The Journal of Biological Chemistry 268: 27012–27019.
13. Ford B, Hornak V, Kleinman H, Nassar N. 2006. Structure of a transient intermediate for GTP hydrolysis by Ras. Structure 14:427–436. doi: 10.1016/j.str.2005.12.010.
14. Gorfe AA, Grant BJ, McCammon JA. 2008. Mapping the nucleotide and isoform-dependent structural and dynamical features of Ras proteins. Structure 16:885–896. doi: 10.1016/j.str.2008.03.009.
15. Gorfe AA, Hanzal-Bayer M, Abankwa D, Hancock JF, McCammon JA. 2007. Structure and dynamics of the fulllength lipid-modified H-Ras protein in a 1,2-dimyristoylglycero-3-phosphocholine bilayer. Journal of Medicinal Chemistry 50:674–684. doi: 10.1021/jm061053f.
16. Goswami D, Gowrishankar K, Bilgrami S, Ghosh S, Raghupathy R, Chadda R, Vishwakarma R, Rao M, Mayor S. 2008. Nanoclusters of GPI-anchored proteins are formed by cortical actin-driven activity. Cell 135:1085–1097. doi: 10.1016/j.cell.2008.11.032.
17. Gremer L, Merbitz-Zahradnik T, Dvorsky R, Cirstea IC, Kratz CP, Zenker M, Wittinghofer A, Ahmadian MR. 2011. Germline KRAS mutations cause aberrant biochemical and physical properties leading to developmental disorders. Human Mutation 32:33–43. doi: 10.1002/humu.21377.
18. Gü ldenhaupt J, Rudack T, Bachler P, Mann D, Triola G, Waldmann H, Kötting C, Gerwert K. 2012. N-Ras forms dimers at POPC membranes. Biophysical Journal 103:1585–1593. doi: 10.1016/j.bpj.2012.08.043.
19. Guzmán C, Bagga M, Kaur A, Westermarck J, Abankwa D. 2014a. ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PLOS ONE 9:e92444. doi: 10.1371/journal.pone.0092444.
20. Guzmán C, Šolman M, Ligabue A, Blaževitš O, Andrade DM, Reymond L, Eggeling C, Abankwa D. 2014b. The efficacy of Raf kinase recruitment to the GTPase H-ras depends on H-ras membrane conformer specific nanoclustering. The Journal of Biological Chemistry 289:9519–9533. doi: 10.1074/jbc.M113.537001.
21. Hancock JF. 2003. Ras proteins: different signals from different locations. Nature Reviews. Molecular Cell Biology 4:373–384. doi: 10.1038/nrm1105.
22. Hedges SB, Blair JE, Venturi ML, Shoe JL. 2004. A molecular timescale of eukaryote evolution and the rise of complex multicellular life. BMC Evolutionary Biology 4:2. doi: 10.1186/1471-2148-4-2.
23. Herrmann C, Martin GA, Wittinghofer A. 1995. Quantitative analysis of the complex between p21ras and the Ras-binding domain of the human Raf-1 protein kinase. The Journal of Biological Chemistry 270:2901–2905. doi: 10.1074/jbc.270.7.2901.
24. John J, Frech M, Wittinghofer A. 1988. Biochemical properties of Ha-ras encoded p21 mutants and mechanism of the autophosphorylation reaction. The Journal of Biological Chemistry 263:11792–11799.
25. John J, Sohmen R, Feuerstein J, Linke R, Wittinghofer A, Goody RS. 1990. Kinetics of interaction of nucleotides with nucleotide-free H-ras p21. Biochemistry 29:6058–6065. doi: 10.1021/bi00477a025.
26. Kapoor S, Triola G, Vetter IR, Erlkamp M, Waldmann H, Winter R. 2012a. Revealing conformational substates of lipidated N-Ras protein by pressure modulation. Proceedings of the National Academy of Sciences of USA 109: 460–465. doi: 10.1073/pnas.1110553109.
27. Kapoor S, Weise K, Erlkamp M, Triola G, Waldmann H, Winter R. 2012b. The role of G-domain orientation and nucleotide state on the Ras isoform-specific membrane interaction. European Biophysics Journal 41:801–813. doi: 10.1007/s00249-012-0841-5.
28. Köhnke M, Schmitt S, Ariotti N, Piggott AM, Parton RG, Lacey E, Capon RJ, Alexandrov K, Abankwa D. 2012. Design and application of in vivo FRET biosensors to identify protein prenylation and nanoclustering inhibitors. Chemistry & Biology 19:866–874. doi: 10.1016/j.chembiol.2012.05.019.
29. Kopra K, Ligabue A, Wang Q, Syrjä npä ä M, Blaževitš O, Veltel S, van Adrichem AJ, Hä nninen P, Abankwa D, Hä rmä H. 2014. A homogeneous quenching resonance energy transfer assay for the kinetic analysis of the GTPase nucleotide exchange reaction. Analytical and Bioanalytical Chemistry 406:4147–4156. doi: 10.1007/s00216-014-7795-7.
30. Kusumi A, Fujiwara TK, Morone N, Yoshida KJ, Chadda R, Xie M, Kasai RS, Suzuki KG. 2012. Membrane mechanisms for signal transduction: the coupling of the meso-scale raft domains to membrane-skeleton-induced compartments and dynamic protein complexes. Seminars in Cell & Developmental Biology 23:126–144. doi: 10.1016/j.semcdb.2012.01.018.
31. Li H, Gorfe AA. 2013. Aggregation of lipid-anchored full-length H-Ras in lipid bilayers: simulations with the MARTINI force field. PLOS ONE 8:e71018. doi: 10.1371/journal.pone.0071018.
32. Lin WC, Iversen L, Tu HL, Rhodes C, Christensen SM, Iwig JS, Hansen SD, Huang WY, Groves JT. 2014. H-Ras forms dimers on membrane surfaces via a protein-protein interface. Proceedings of the National Academy of Sciences of USA 111:2996–3001. doi: 10.1073/pnas.1321155111.
33. Mazhab-Jafari MT, Marshall CB, Smith MJ, Gasmi-Seabrook GM, Stathopulos PB, Inagaki F, Kay LE, Neel BG, Ikura M. 2015. Oncogenic and RASopathy-associated K-RAS mutations relieve membrane-dependent occlusion of the effector-binding site. Proceedings of the National Academy of Sciences of USA 112:6625–6630. doi: 10.1073/pnas.1419895112.
34. Meijering E, Jacob M, Sarria JC, Steiner P, Hirling H, Unser M. 2004. Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images. Cytometry 58:167–176. doi: 10.1002/cyto.a.20022.
35. Muratcioglu S, Chavan TS, Freed BC, Jang H, Khavrutskii L, Freed RN, Dyba MA, Stefanisko K, Tarasov SG, Gursoy A, Keskin O, Tarasova NI, Gaponenko V, Nussinov R. 2015. GTP-dependent K-ras dimerization. Structure 23: 1325–1335. doi: 10.1016/j.str.2015.04.019.
36. Najumudeen AK, Köhnke M, Solman M, Alexandrov K, Abankwa D. 2013. Cellular FRET-biosensors to detect membrane targeting inhibitors of n-Myristoylated proteins. PLOS ONE 8:e66425. doi: 10.1371/journal.pone.0066425.
37. Nan X, Collisson EA, Lewis S, Huang J, Tamgü ney TM, Liphardt JT, McCormick F, Gray JW, Chu S. 2013. Singlemolecule superresolution imaging allows quantitative analysis of RAF multimer formation and signaling. Proceedings of the National Academy of Sciences of USA 110:18519–18524. doi: 10.1073/pnas.1318188110.
38. Nan X, Tamgü ney TM, Collisson EA, Lin LJ, Pitt C, Galeas J, Lewis S, Gray JW, McCormick F, Chu S. 2015. Ras-gtp dimers activate the Mitogen-activated protein kinase (MAPK) pathway. Proceedings of the National Academy of Sciences of USA 112:7996–8001. doi: 10.1073/pnas.1509123112.
39. Nussinov R, Tsai CJ. 2015. ‘Latent drivers’ expand the cancer mutational landscape. Current Opinion in Structural Biology 32:25–32. doi: 10.1016/j.sbi.2015.01.004.
40. Paz A, Haklai R, Elad-Sfadia G, Ballan E, Kloog Y. 2001. Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation. Oncogene 20:7486–7493. doi: 10.1038/sj.onc.1204950.
41. Plowman SJ, Ariotti N, Goodall A, Parton RG, Hancock JF. 2008. Electrostatic interactions positively regulate K-Ras nanocluster formation and function. Molecular and Cellular Biology 28:4377–4385. doi: 10.1128/MCB.00050-08.
42. Plowman SJ, Muncke C, Parton RG, Hancock JF. 2005. H-ras, K-ras, and inner plasma membrane raft proteins operate in nanoclusters with differential dependence on the actin cytoskeleton. Proceedings of the National Academy of Sciences of USA 102:15500–15505. doi: 10.1073/pnas.0504114102.
43. Prior IA, Lewis PD, Mattos C. 2012. A comprehensive survey of Ras mutations in cancer. Cancer Research 72: 2457–2467. doi: 10.1158/0008-5472.CAN-11-2612.
44. Prior IA, Muncke C, Parton RG, Hancock JF. 2003a. Direct visualization of Ras proteins in spatially distinct cell surface microdomains. The Journal of Cell Biology 160:165–170. doi: 10.1083/jcb.200209091.
45. Prior IA, Parton RG, Hancock JF. 2003b. Observing cell surface signaling domains using electron microscopy. Science’s STKE 2003:PL9. doi: 10.1126/stke.2003.177.pl9.
46. Rotblat B, Belanis L, Liang H, Haklai R, Elad-Zefadia G, Hancock JF, Kloog Y, Plowman SJ. 2010. H-Ras nanocluster stability regulates the magnitude of MAPK signal output. PLOS ONE 5:e11991. doi: 10.1371/journal.pone.0011991.
47. Scheffzek K, Ahmadian MR, Kabsch W, Wiesmü ller L, Lautwein A, Schmitz F, Wittinghofer A. 1997. The Ras-RasGAP complex: structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science 277: 333–338. doi: 10.1126/science.277.5324.333.
48. Schubbert S, Shannon K, Bollag G. 2007. Hyperactive Ras in developmental disorders and cancer. Nature Reviews Cancer 7:295–308. doi: 10.1038/nrc2109.
49. Shin SI, Freedman VH, Risser R, Pollack R. 1975. Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. Proceedings of the National Academy of Sciences of USA 72:4435–4439. doi: 10.1073/pnas.72.11.4435.
50. Smith G, Bounds R, Wolf H, Steele RJ, Carey FA, Wolf CR. 2010. Activating K-Ras mutations outwith ‘hotspot’ codons in sporadic colorectal tumours—implications for personalised cancer medicine. British Journal of Cancer 102:693–703. doi: 10.1038/sj.bjc.6605534.
51. Spiegel J, Cromm PM, Zimmermann G, Grossmann TN, Waldmann H. 2014. Small-molecule modulation of Ras signaling. Nature Chemical Biology 10:613–622. doi: 10.1038/nchembio.1560.
52. Tian T, Harding A, Inder K, Plowman S, Parton RG, Hancock JF. 2007. Plasma membrane nanoswitches generate high-fidelity Ras signal transduction. Nature Cell Biology 9:905–914. doi: 10.1038/ncb1615.
53. Vaudry D, Stork PJ, Lazarovici P, Eiden LE. 2002. Signaling pathways for PC12 cell differentiation: making the right connections. Science 296:1648–1649. doi: 10.1126/science.1071552.
54. Zhou Y, Cho KJ, Plowman SJ, Hancock JF. 2012. Nonsteroidal anti-inflammatory drugs alter the spatiotemporal organization of ras proteins on the plasma membrane. The Journal of Biological Chemistry 287:16586–16595. doi: 10.1074/jbc.M112.348490.